More interesting abstracts to present on AACR Annual Meeting 2015 April 18 - 22, 2015
Presentation Title: Discovery of AP26113, a potent, orally active inhibitor of anaplastic lymphoma kinase and clinically relevant mutants
Presentation Title: The potent ALK inhibitor AP26113 can overcome mechanisms of resistance to first- and second-generation ALK TKIs in preclinical models
Presentation Title: Ponatinib demonstrates antitumor activity in RET- and FGFR-driven patient-derived xenografts
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.